UNC Health and UNC School of Medicine

The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.

A doctor using gliding an ultrasound probe over a male patient's belly.

The UNC School of Medicine is on pace to become one of the few sites in the United States to incorporate intestinal ultrasound as an imaging technique for managing Inflammatory Bowel Disease.

Tag: Gastroenterology

How New Drug Approvals are Reshaping Treatment for Eosinophilic Esophagitis

A New Ultrasound Technology is Revolutionizing IBD Care at UNC School of Medicine